A prospective study of influenza vaccination and a comparison of immunologic parameters in children and adults with chromosome 22q11.2 deletion syndrome (DiGeorge Syndrome/Velocardiofacial Syndrome)

Journal of Clinical Immunology

Volumn 31, Issue 6, 2011, Pages 927-935

  Jawad, Abbas F ^a   Prak, Eline Luning ^b   Boyer, Jean ^c   McDonald McGinn, Donna M ^a   Zackai, Elaine ^a   McDonald, Kenyetta ^a   Sullivan, Kathleen E ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

B cell differentiation; DiGeorge syndrome; Homeostatic proliferation; Influenza; T cell senescence; Vaccine

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CHILD; CHROMOSOME DELETION 22Q11; CLINICAL ARTICLE; CONTROLLED STUDY; DIGEORGE SYNDROME; FLOW CYTOMETRY; HUMAN; INFANT; INFLUENZA; INFLUENZA VACCINATION; LYMPHOCYTE FUNCTION; MEMORY CELL; PRE B LYMPHOCYTE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGULATORY T LYMPHOCYTE; T CELL DEPLETION; VELOCARDIOFACIAL SYNDROME;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; B-LYMPHOCYTES; CELLS, CULTURED; CHILD, PRESCHOOL; CHROMOSOMES, HUMAN, PAIR 22; CYTOKINES; DIGEORGE SYNDROME; ENZYME-LINKED IMMUNOSPOT ASSAY; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNOPHENOTYPING; INFANT; INFLUENZA VACCINES; INFLUENZA, HUMAN; PROSPECTIVE STUDIES; T-LYMPHOCYTES;

EID: 84860392240     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-011-9569-8     Document Type: Article

References (54)

1. DiGeorge AM. Congenital absence of the thymus and its immunological consequences: concurrance with congenital hypo-thyroidism. Birth Defects. 1968;4:116-21.
2. Oskarsdottir S, Vujic M, Fasth A. Incidence and prevalence of the 22q11 deletion syndrome: a population-based study in Western Sweden. Arch Dis Child. 2004;89:148-51. (Pubitemid 38168974)
3. McDonald-McGinn DM, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore). 2011;90:1-18.
4. Oskarsdottir S, Persson C, Eriksson BO, Fasth A. Presenting phenotype in 100 children with the 22q11 deletion syndrome. Eur J Pediatr. 2005;164:146-53. (Pubitemid 40558177)
5. Vantrappen G, Devriendt K, Swillen A, Rommel N, Vogels A, Eyskens B, et al. Presenting symptoms and clinical features in 130 patients with the velo-cardio-facial syndrome. The Leuven experience. Genet Couns. 1999;10:3-9. (Pubitemid 129783861)
6. McDonald-McGinn DM, Kirschner R, Goldmuntz E, Sullivan K, Eicher P, Gerdes M, et al. The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns. 1999;10:11-24. (Pubitemid 29121796)
7. Ryan AK, Goodship JA, Wilson DI, Philip N, Levy A, Seidel H, et al. Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. J Med Genet. 1997;34:798-804. (Pubitemid 27417432)
8. Chinen J, Rosenblatt HM, Smith EO, Shearer WT, Noroski LM. Long-term assessment of T-cell populations in DiGeorge syndrome. J Allergy Clin Immunol. 2003;111:573-9. (Pubitemid 36337879)
9. Piliero LM, Sanford AN, McDonald-McGinn DM, Zackai EH, Sullivan KE. T-cell homeostasis in humans with thymic hypopla-sia due to chromosome 22q11.2 deletion syndrome. Blood. 2004;103:1020-5. (Pubitemid 38129565)
10. Pierdominici M, Mazzetta F, Caprini E, Marziali M, Digilio MC, Marino B, et al. Biased T-cell receptor repertoires in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Exp Immunol. 2003;132:323-31. (Pubitemid 36560631)
11. Cancrini C, Romiti ML, Finocchi A, Di Cesare S, Ciaffi P, Capponi C, et al. Post-natal ontogenesis of the T-cell receptor CD4 and CD8 Vbeta repertoire and immune function in children with DiGeorge syndrome. J Clin Immunol. 2005;25:265-74. (Pubitemid 40884053)
12. Pierdominici M, Marziali M, Giovannetti A, Oliva A, Rosso R, Marino B, et al. T cell receptor repertoire and function in patients with DiGeorge syndrome and velocardiofacial syndrome. Clin Exp Immunol. 2000;121:127-32. (Pubitemid 30436025)
13. Zemble R, Luning Prak E, McDonald K, McDonald-McGinn D, Zackai E, Sullivan K. Secondary immunologic consequences in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Clin Immunol. 2010;136:409-18.
14. Seder RA, Ahmed R. Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat Immunol. 2003;4:835-42. (Pubitemid 37098653)
15. Baars PA, Maurice MM, Rep M, Hooibrink B, van Lier RA. Heterogeneity of the circulating human CD4+ T cell population. Further evidence that the CD4+CD45RA-CD27-T cell subset contains specialized primed T cells. J Immunol. 1995;154:17-25.
16. Tanaskovic S, Fernandez S, Price P, Lee S, French MA. CD31 (PECAM-1) is a marker of recent thymic emigrants among CD4+ T-cells, but not CD8+ T-cells or gammadelta T-cells, in HIV patients responding to ART. Immunol Cell Biol. 2010;88:321-7.
17. Sallusto F, Langenkamp A, Geginat J, Lanzavecchia A. Functional subsets of memory T cells identified by CCR7 expression. Curr Top Microbiol Immunol. 2000;251:167-71.
18. Wherry EJ, Teichgraber V, Becker TC, Masopust D, Kaech SM, Antia R, et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol. 2003;4:225-34. (Pubitemid 36322131)
19. Sutter JA, Kwan-Morley J, Dunham J, Du YZ, Kamoun M, Albert D, et al. A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): factors associated with B lymphocyte recovery. Clin Immunol. 2008;126:282-90.
20. Stadtmauer EA, Vogl DT, Luning Prak E, Boyer J, Aqui NA, Rapoport AP, et al. Transfer of influenza vaccine-primed costimu-lated autologous T cells after stem cell transplantation for multiple myeloma leads to reconstitution of influenza immunity: results of a randomized clinical trial. Blood. 2011;117:63-71.
21. Duty JA, Szodoray P, Zheng NY, Koelsch KA, Zhang Q, Swiatkowski M, et al. Functional anergy in a subpopulation of naive B cells from healthy humans that express autoreactive immunoglobulin receptors. J Exp Med. 2009;206:139-51.
22. Griffin DO, Holodick NE, Rothstein TL. Human B1 cells in umbilical cord and adult peripheral blood express the novel phenotype CD20+ CD27+ CD43+ CD70. J Exp Med. 2011;208:67-80.
23. Di Fabio S, Mbawuike IN, Kiyono H, Fujihashi K, Couch RB, McGhee JR. Quantitation of human influenza virus-specific cytotoxic T lymphocytes: correlation of cytotoxicity and increased numbers of IFN-gamma producing CD8+ T cells. Int Immunol. 1994;6:11-9. (Pubitemid 24040329)
24. Crotty S, Aubert RD, Glidewell J, Ahmed R. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods. 2004;286:111-22. (Pubitemid 38490401)
25. Levin MJ, Song LY, Fenton T, Nachman S, Patterson J, Walker R, et al. Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children. Vaccine. 2008;26:4210-7.
26. Sullivan KE, McDonald-McGinn D, Zackai EH. CD4(+) CD25(+) T-cell production in healthy humans and in patients with thymic hypoplasia. Clin Diagn Lab Immunol. 2002;9:1129-31. (Pubitemid 34988488)
27. McLean-Tooke A, Barge D, Spickett GP, Gennery AR. Immuno-logic defects in 22q11.2 deletion syndrome. J Allergy Clin Immunol. 2008;122:362-7.
28. Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity. 2011;34:108-21.
29. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol. 1996;14:233-58. (Pubitemid 26130184)
30. Borrow P, Tough DF, Eto D, Tishon A, Grewal IS, Sprent J, et al. CD40 ligand-mediated interactions are involved in the generation of memory CD8(+) cytotoxic T lymphocytes (CTL) but are not required for the maintenance of CTL memory following virus infection. J Virol. 1998;72:7440-9. (Pubitemid 28377875)
31. Grewal IS, Flavell RA. CD40 and CD154 in cell-mediated immunity. Annu Rev Immunol. 1998;16:111-35. (Pubitemid 28183361)
32. Conley ME, Beckwith JB, Mancer JF, Tenckhoff L. The spectrum of the DiGeorge syndrome. J Pediatr. 1979;94:883-90. (Pubitemid 9150217)
33. Bastian J, Law S, Vogler L, Lawton A, Herrod H, Anderson S, et al. Prediction of persistent immunodeficiency in the DiGeorge anomaly. J Pediatr. 1989;115:391-6. (Pubitemid 19223172)
34. Sullivan KE, McDonald-McGinn D, Driscoll D, Emanuel BS, Zackai EH, Jawad AF. Longitudinal analysis of lymphocyte function and numbers in the first year of life in chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/ velocardiofacial syndrome). Clin Diagn Lab Immunol. 1999;6:906-11. (Pubitemid 29529986)
35. Sirianni MC, Businco L, Fiore L, Seminara R, Aiuti F. T-cell subsets and natural killer cells in DiGeorge and SCID patients. Birth Defects Orig Artic Ser. 1983;19:107-8. (Pubitemid 14164534)
36. Jawad AF, McDonald-McGinn DM, Zackai E, Sullivan KE. Immunologic features of chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). J Pediatr. 2001;139:715-23. (Pubitemid 33097439)
37. Gennery AR, Barge D, O'Sullivan JJ, Flood TJ, Abinun M, Cant AJ. Antibody deficiency and autoimmunity in 22q11.2 deletion syndrome. Arch Dis Child. 2002;86:422-5. (Pubitemid 34596653)
38. Lavi RF, Kamchaisatian W, Sleasman JW, Martin DP, Haraguchi S, Day NK, et al. Thymic output markers indicate immune dysfunction in DiGeorge syndrome. J Allergy Clin Immunol. 2006;118:1184-6. (Pubitemid 44666988)
39. Davis CM, Kancherla VS, Reddy A, Chan W, Yeh HW, Noroski LM, et al. Development of specific T-cell responses to Candida and tetanus antigens in partial DiGeorge syndrome. J Allergy Clin Immunol. 2008;122:1194-9.
40. Markert ML, Sarzotti M, Ozaki DA, Sempowski GD, Rhein ME, Hale LP, et al. Thymus transplantation in complete DiGeorge syndrome: immunologic and safety evaluations in 12 patients. Blood. 2003;102:1121-30. (Pubitemid 36917815)
41. Markert ML, Watson TJ, McLaughlin TM, McGuire CA, Ward FE, Kostyu D, et al. Development of T-cell function after postnatal thymic transplanation for DiGeorge syndrome. Am J Hum Genet. 1995;57:A14.
42. Markert ML, Alexieff MJ, Li J, Sarzotti M, Ozaki DA, Devlin BH, et al. Complete DiGeorge syndrome: development of rash, lymphadenopathy, and oligoclonal T cells in 5 cases. J Allergy Clin Immunol. 2004;113:734-41. (Pubitemid 38530431)
43. Markert ML, Boeck A, Hale LP, Kloster AL, McLaughlin TM, Batchvarova MN, et al. Transplantation of thymus tissue in complete DiGeorge syndrome. N Engl J Med. 1999;341:1180-9. (Pubitemid 29480656)
44. Okada R, Kondo T, Matsuki F, Takata H, Takiguchi M. Phenotypic classification of human CD4+ T cell subsets and their differentiation. Int Immunol. 2008;20:1189-99.
45. Sallusto F, Geginat J, Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation, and maintenance. Annu Rev Immunol. 2004;22:745-63. (Pubitemid 38680440)
46. Barthlott T, Kassiotis G, Stockinger B. T cell regulation as a side effect of homeostasis and competition. J Exp Med. 2003;197:451-60. (Pubitemid 36278601)
47. Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ, et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science. 2002;298:850-4. (Pubitemid 35231542)
48. Elder DA, Kaiser-Rogers K, Aylsworth AS, Calikoglu AS. Type I diabetes mellitus in a patient with chromosome 22q11.2 deletion syndrome. Am J Med Genet. 2001;101:17-9. (Pubitemid 32429904)
49. Etzioni A, Pollack S. Autoimmune phenomena in DiGeorge syndrome letter; comment. Israel J Med Sci. 1994;30:853.
50. Davies JK, Telfer P, Cavenagh JD, Foot N, Neat M. Autoimmune cytopenias in the 22q11.2 deletion syndrome. Clin Lab Haematol. 2003;25:195-7. (Pubitemid 36754231)
51. Bassett AS, Chow EW, Husted J, Weksberg R, Caluseriu O, Webb GD, et al. Clinical features of 78 adults with 22q11 deletion syndrome. Am J Med Genet A. 2005;138:307-13. (Pubitemid 41532946)
52. Finocchi A, Di Cesare S, Romiti ML, Capponi C, Rossi P, Carsetti R, et al. Humoral immune responses and CD27+ B cells in children with DiGeorge syndrome (22q11.2 deletion syndrome). Pediatr Allergy Immunol. 2006;17:382-8. (Pubitemid 43989962)
53. Smith CA, Driscoll DA, Emanuel BS, McDonald-McGinn DM, Zackai EH, Sullivan KE. Increased prevalence of immunoglobulin A deficiency in patients with the chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/ velocardiofacial syndrome). Clin Diagn Lab Immunol. 1998;5:415-7. (Pubitemid 28246471)
54. Junker AK, Driscoll DA. Humoral immunity in DiGeorge syndrome. J Pediatr. 1995;127:231-7.